A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.

The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Serena Williams is opening up about her fitness journey, revealing that she uses the injectable GLP-1 weight loss drug ...

In a recent video spot, the 43-year-old athlete reveals that Ro helped her lose 31 pounds in eight months. “Yes, I’m on Ro.

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...

Celebrities have access to doctors that most others don’t,” Jameela Jamil flags the risks of GLP-1s like those Serena ...

At 43, Serena Williams has revealed she lost 31 pounds using Zepbound after years of struggling to return to her ...

Zepbound led to an average weight loss of 20.2 percent compared to Wegovy's 13.7 percent. We talked with healthcare experts to understand the study’s findings, what sets these drugs apart and ...

Can Novo Nordisk and Eli Lilly regain their former stock market glory? A lot is riding on next year's pills ...

Serena Williams revealed she's been using Zepbound for weight loss after childbirth after fans started commenting on her ...